Mark T. Vander Lugt, MD, Xiaohua Chen, MD, Maria Escolar, MD Beth Carella, DO, Jessie Barnum, MD, Randy Windreich, MD, Memphis J Hill BS, Rebecca Marsh, MD, Heather Stanczak, MT(ASCP), Elizabeth O. Stenger, MD and Szabolcs P. Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for non-malignant disorders. Blood Advances, 2020 in Press
Xiaohua Chen, Vander Lugt MT, Hill M, Escolar M, Chen W, Szabolcs P . Rapid Reconstitution of Treg Subsets is Associated with Reduced Rates of GvHD and Absence of Viremia after Cord Blood Transplantation in Children with Reduced-Intensity Conditioning Utilizing Alemtuzumab. Cytotherapy, 2020 In Press
Hsu AP, Donkó A, Arrington ME, Swamydas M, Fink D, Das A, Escobedo O, Bonagura V, Szabolcs P, Steinberg HN, Bergerson J, Skoskiewicz A, Makhija M, Davis J, Foruraghi L, Palmer C, Fuleihan RL, Church JA, Bhandoola A, Lionakis MS, Campbell S, Leto TL, Kuhns DB, Holland SM. Dominant Activating RAC2 Mutation With Lymphopenia, Immunodeficiency, and Cytoskeletal Defects. Blood2019 May 2;133(18):1977
Dreyzin A, Michaels MG, Vander Lugt MT, Szabolcs P. Oral ribavirin for paramyxovirus infection after alemtuzumab-containing reduced-intensity conditioning HCT regimen. Pediatr Transplant 2019;23 Jan 27 e13358
Forbes LR, Vogel TP, Cooper MA, Castro-Wagner J, Schussler E, Weinacht KG, Plant AS, Su HC, Allenspach EJ, Slatter M, Abinun M, Lilic D, Cunningham-Rundles C, Eckstein O, Olbrich P, Guillerman RP, Patel NC, Demirdag YY, Zerbe C, Freeman AF, Holland SM, Szabolcs P, Gennery A, Torgerson TR, Milner JD, Leiding JW. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT) or STAT3 mutations. J. Allergy Clin Immunol.2018 Nov. 142(5)-1665-1669. doi: 10.1016/j.jaci.2018.07.020. Epub 2018 Aug 6, PMID:30092289
Mehta RS, Chen X, Antony J, Boyiadzis M, Szabolcs P. Generating peripheral blood derived lymphocytes reacting against autologous primary AML blasts. Journal of Immunotherapy. 2016;39(2):71-80, PMID: 26849076
Szabolcs P, Buckley R, Davis R, Moffet J, Voynow J, Jeyaraj A, Chen X, Sempowski G, Zaas D. Tolerance After Lung and Bone Marrow Transplantation from an Unrelated Cadaveric Donor. Journal of Allergy and Clinical Immunology, 2015 Feb;135 (2):567-70.
Parikh SH, Mendizabal A, Benjamin CL, Komanduri KV, Antony J, Petrovic A, Hale G, Driscoll TA, Martin PL, Page KM, Flickinger K, Moffet J, Niedzwiecki, D, Kurtzberg, J, Szabolcs P. A Novel Reduced-Intensity Conditioning Regimen for Unrelated Umbilical Cord Blood Transplantation in Children with Nonmalignant Diseases. Biol Blood Marrow Transplantation, 2014 Mar;20(3):326-36, PMID: 24296492
Davis CC, Marti L, Sempowski G, Jeyaraj DA, Szabolcs P. IL-7 permits Th1/Tc1 maturation of cord blood T cells while enhances ex vivo expansion in collaboration with CD3/CD28 costimulatory beads and Il-2: A critical step towards adoptive immunotherapy. Cancer Research, 2010 Jul 1;70(13):5249
Mazur AM, Davis CC, and Szabolcs P. Ex vivo expansion and Th1/Tc1 maturation of umbilical cord blood T cells by CD3/CD28 costimulation. Biol. Blood and Marrow Transplantation, 2008 Oct;14(10):1190-6. PMID: 18804050
Szabolcs P and Niedzwiecki, D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy, 2007, 9(2):111-122
Park KD, Marti L, Kurtzberg J, Szabolcs P. In vitro priming and expansion of Cytomegalovirus-specific Th1 and Tc1 T cells from naïve cord blood lymphocytes. Blood, 2006 Sep 1, 108(5):1770.